What amount sold does Compact Medical Inc. report in Form D filings?

The latest linked filings report $2.2M sold across 4 identified offering(s). 0 unlinked amendment(s) are excluded; 0 offering(s) have no reported amount sold. This is not verified lifetime funding or money raised during a specific period.

When was Compact Medical Inc.'s most recent SEC filing?

Compact Medical Inc.'s most recent Form D filing was on 2025-09-09.

How many investors does Compact Medical Inc. have?

The most recent Form D filing lists 2 investor(s).

What type of securities does Compact Medical Inc. offer?

Compact Medical Inc.'s SEC Form D filings indicate equity offerings.

Compact Medical Inc.

CIK: 0001794240·Biotechnology·INDIANAPOLIS, IN·Corporation·Founded 2021

Reported Sold

$2,184,999

Total Filings

Identified Offerings

Last Filed

Sep 9, 2025

Employees

—

Reported sold uses the latest linked filing for each identified offering; it is not verified lifetime funding. SPV filings are shown separately.

About

Company in Biotechnology industry

SEC EDGAR

Offering filing timeline

Sep 9, 2025Form D — New notice

Reported sold: $199,999 · Target: $4,500,000

Rule 506(b)·2 investors

Nov 26, 2024Form D/A — Amendment

Reported sold: $685,000 · Target: $1,500,000

Rule 506(b)·7 investors

Changed: Reported amount sold, Offering target, Reported investors

Nov 30, 2023Form D — New notice

Reported sold: $350,000 · Target: $600,000

Rule 506(b)·2 investors

May 28, 2021Form D/A — Amendment

Reported sold: $1,215,000 · Target: $1,700,000

Rule 506(b)·18 investors

Changed: Reported amount sold, Offering target, Reported investors

Sep 14, 2020Form D — New notice

Reported sold: $150,000 · Target: $1,200,000

Rule 506(b)·1 investor

Nov 22, 2019Form D — New notice

Reported sold: $85,000 · Target: $85,000

Rule 506(b)·6 investors

Fundraising Profile

Exemptions

Rule 506(b)

Investors in latest filing

Revenue Range

Decline to Disclose

Reported commissions across identified offerings

Amendment Rate

33%

Latest reported sold across 4 identified offerings

$2,184,999

Uses the latest linked filing for each offering. This is not a measure of money raised in the last year or verified lifetime funding.

Key People

Adam Scott

Related Person

Appears on 5 filings

Jonathan Merrell

Related Person

Appears on 3 filings

Natalie Christenson

Related Person

Appears on 3 filings

Jonathan G. Merrell

Related Person

Appears on 2 filings

Allan Matthys

Related Person

Appears on 2 filings

Jonathan Glen Merrell

Related Person

Appears on 1 filing

Filing History

Date	Type	Offering target	Reported sold	Investors
Sep 9, 2025	New	$4,500,000	$199,999	2
Nov 26, 2024	Amendment	$1,500,000	$685,000	7
Nov 30, 2023	New	$600,000	$350,000	2
May 28, 2021	Amendment	$1,700,000	$1,215,000	18
Sep 14, 2020	New	$1,200,000	$150,000	1
Nov 22, 2019	New	$85,000	$85,000	6

Filing History

Amendment insights

Loading amendment history…

Comparable issuers

Matched on reported industry and issuer type, then ranked by business location, offering target, and recency. These are filing comparables, not verified business competitors.

Swep Bio, Inc.

Biotechnology

Offering target: $4,999,976

Filed Oct 29, 2026